Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0383820000480050682
Tuberculosis and Respiratory Diseases
2000 Volume.48 No. 5 p.682 ~ p.698
Inhibitory Mechanism on NF-¥êB Transactivation by Dexamethasone in Pulmonary Epithelial Cells
1À̰迵/1Kye Young Lee
1±èÀ±¼·/1°í¹ÌÇý/1¹ÚÀç¼®/1Áö¿µ±¸/1±è°Ç¿­/2°ü»óÁØ/1Yoon Seop Kim/1Mi Hye Ko/1Jae Seok Park/1Young Koo Jee/1keun Youl Kim/2Sahng June Kwak
Abstract
-Abstract-
Glucocorticoid receptor (GR) functions as a suppressor of inflammation by inhibiting
the expression of many cytokine gene activated by NF-¥êB. The goal of this study is
to investigate the mechanism by which GR repress NF-¥êB activation in lung epithelial
cells. We used A549 and BEAS-2B lung epithelial cell lines. Using IgG¥ê-NF-¥êB
luciferase reporter gene construct, we found that dexamethasone significantly suppressed
TNF-¥á-induced NF-¥êB activation and the overexpression of GR showed
dose-dependent reduction of TNF-¥á-induced NF-¥êB activity in both cell lines.
However, DNA binding of NF-¥êB induced by TNF-¥á in electromobility shift assay
was not inhibited by dexamethasone. Super shift assay with anti-p65 antibody
demonstrated the existence of p65 in NF-¥êB complex induced by TNF-¥á Western blot
showed that I¥êB¥á degradation induced by TNF-¥á was not affected by dexamethasone
and I¥êB¥ê was not induced by dexamethasone, neither. To evaluate p65 specific
transactivation, we adopted co-transfection study of Ga14-p65TA1 or TA2 fusion protein
expression system together with 5xGa14-luciferase vector. Co-transfection of GR with
Ga14-p65TA1 or TA2 repressed luciferase activity profoundly to the level of 10-20% of
p65TA1- or TA2-induced transcriptional activity. And this transrepressional effect was
abolished by co-transfection of CBP or SRC-1 expression vectors. These results suggest
that Gr-mediated transrepression of NF-¥êB in lung epithelial cells is through competing
for binding to limiting amount of transcriptional coactivators, CBP or SRC-1.
KEYWORD
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø